CBLL1 and cancer: Apart from silencing approaches, small molecule inhibitors targeting specifically an individual E3 ligase, as previously realized by Hakin-1, a specific inhibitor of the E3 ligase Hakai, represents another promising therapeutic approach for interfering with cancer progression [146].